Bed Bath & Beyond falls following Q4 results Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Galectin Therapeutics (GALT) up 26% after announcing that a paper published in the peer-reviewed Journal for ImmunoTherapy of Cancer provided "further clinical evidence" that using belapectin in combination with pembrolizumab significantly enhances tumor response to immunotherapy in patients with advanced metastatic melanoma and head and neck squamous cell carcinoma
- Berry Petroleum (BRY) up 10% after KeyBanc analyst Leo Mariani upgraded shares to Overweight from Sector Weight with a $9 price target.
- Amicus (FOLD) up 5% after Cantor Fitzgerald analyst Kristen Kluska upgraded the stock to Overweight from Neutral with a $17 price target
UP AFTER EARNINGS -
- Goldman Sachs (GS) up 1%
- Lovesac (LOVE) up 6%
DOWN AFTER EARNINGS -
- Bed Bath & Beyond (BBBY) down 8%
- Infosys (INFY) down 3%
LOWER -
- Discovery (DISCA) down 4% after a 19M share block trade priced at $38.40
- iQIYI (IQ) down 4% after a 35M share block trade priced at $15.85
- Stitch Fix (SFIX) down 3% after announcing CEO Katrina Lake will transition to the role of executive chairperson of the board and that the board will be appointing president Elizabeth Spaulding to the role of CEO
Symbols:
GALT BRY FOLD GS LOVE BBBY INFY DISCA IQ SFIX Keywords: Fly Intel, Wall Street, Top Stories, Stocks